tobanum has been researched along with Coronary Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ol'binskaia, LI; Vartanova, OA | 1 |
| Butenko, AG; Korkushko, OV; Shatilo, VB | 1 |
| Burdiashvili, BSh; Gambashidze, NB; Kikodze, NL; Kobaladze, SG; Mamaladze, GT | 1 |
3 other study(ies) available for tobanum and Coronary Disease
| Article | Year |
|---|---|
[Clinical and cardiohemodynamic effects of the new long-acting beta-blocker tobanum].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Cardiac Complexes, Premature; Coronary Disease; Female; Heart; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nadolol; Propanolamines; Propranolol | 1986 |
[Effectiveness of tobanum and visken in ischemic heart disease with extrasystole].
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Cardiac Complexes, Premature; Coronary Disease; Drug Evaluation; Drug Therapy, Combination; Humans; Middle Aged; Pindolol; Propanolamines; Time Factors | 1989 |
[Effect of tobanum on various functions of the heart in patients with ischemic heart disease and prospects for its clinical application].
Topics: Adrenergic beta-Antagonists; Adult; Coronary Disease; Drug Therapy, Combination; Heart; Hemodynamics; Humans; Middle Aged; Myocardial Contraction; Nifedipine; Physical Exertion; Propanolamines | 1985 |